VCYT Description — Veracyte Inc

Veracyte is a genomic diagnostics company. Co.'s products include the following: Afirma Genomic Sequencing Classifier and Xpression Atlas, which includes the Afirma GSC and Xpression Atlas; Percepta Bronchial Genomic Classifier, which improves lung cancer diagnosis by improving the performance of diagnostic bronchoscopies; Envisia Genomic Classifier, which improves diagnosis of idiopathic pulmonary fibrosis; and Prosigna Breast Cancer Prognostic Gene Signature Assay, which uses genomic technology to inform next steps for patients with early-stage breast cancer, based on the genomic make-up of their disease.

Company Name: 
Veracyte Inc
Number of ETFs Holding VCYT: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   VCYT Weight   VCYT Amount 
 VTI   0.01%   $90,902,324         
 VB   0.06%   $79,621,788         
 IWM   0.11%   $72,863,112         
 XBI   0.85%   $61,983,413         
 VBK   0.13%   $50,315,344         
 VXF   0.04%   $45,944,867         
 IWN   0.23%   $34,841,562         
 IBB   0.23%   $25,458,252         
 VHT   0.05%   $10,037,069         
 VTWO   0.11%   $7,141,885         
List of all 32 ETFs holding VCYT »
Quotes delayed 20 minutes

Buy (2.96 out of 4)
16th percentile
(ranked lower than approx. 84% of all stocks covered)

Analysts Forecast:
VCYT Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding VCYT | Veracyte Inc | ETF Channel |

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.